102 related articles for article (PubMed ID: 26048090)
1. Stability, toxicity and intestinal permeation enhancement of two food-derived antihypertensive tripeptides, Ile-Pro-Pro and Leu-Lys-Pro.
Gleeson JP; Heade J; Ryan SM; Brayden DJ
Peptides; 2015 Sep; 71():1-7. PubMed ID: 26048090
[TBL] [Abstract][Full Text] [Related]
2. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PepT1 transport of food-derived antihypertensive peptides, Ile-Pro-Pro and Leu-Lys-Pro using in vitro, ex vivo and in vivo transport models.
Gleeson JP; Brayden DJ; Ryan SM
Eur J Pharm Biopharm; 2017 Jun; 115():276-284. PubMed ID: 28315445
[TBL] [Abstract][Full Text] [Related]
4. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
5. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
7. Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models.
Aguirre TA; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):856-65. PubMed ID: 25445305
[TBL] [Abstract][Full Text] [Related]
8. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
Brayden DJ; Stuettgen V
Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
[TBL] [Abstract][Full Text] [Related]
9. Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery.
Khalid Danish M; Gleeson JP; Brayden DJ; Byrne HJ; Frías JM; Ryan SM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232463
[TBL] [Abstract][Full Text] [Related]
10. Transport Study of Egg-Derived Antihypertensive Peptides (LKP and IQW) Using Caco-2 and HT29 Coculture Monolayers.
Xu Q; Fan H; Yu W; Hong H; Wu J
J Agric Food Chem; 2017 Aug; 65(34):7406-7414. PubMed ID: 28782363
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of ACE inhibitory tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in vascular endothelial cells.
Kawaguchi K; Nakamura T; Kamiie J; Takahashi T; Yamamoto N
Biosci Biotechnol Biochem; 2012; 76(9):1792-5. PubMed ID: 22972320
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models.
Foltz M; Cerstiaens A; van Meensel A; Mols R; van der Pijl PC; Duchateau GS; Augustijns P
Peptides; 2008 Aug; 29(8):1312-20. PubMed ID: 18490081
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
14. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis.
Yamaguchi N; Kawaguchi K; Yamamoto N
Eur J Pharmacol; 2009 Oct; 620(1-3):71-7. PubMed ID: 19686729
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
16. Producibility and digestibility of antihypertensive beta-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion.
Ohsawa K; Satsu H; Ohki K; Enjoh M; Takano T; Shimizu M
J Agric Food Chem; 2008 Feb; 56(3):854-8. PubMed ID: 18193838
[TBL] [Abstract][Full Text] [Related]
17. An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.
Bzik VA; Brayden DJ
Pharm Res; 2016 Oct; 33(10):2506-16. PubMed ID: 27387171
[TBL] [Abstract][Full Text] [Related]
18. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
19. Transport of Antihypertensive Peptide RVPSL, Ovotransferrin 328-332, in Human Intestinal Caco-2 Cell Monolayers.
Ding L; Wang L; Zhang Y; Liu J
J Agric Food Chem; 2015 Sep; 63(37):8143-50. PubMed ID: 26335384
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats.
Nakano D; Ogura K; Miyakoshi M; Ishii F; Kawanishi H; Kurumazuka D; Kwak CJ; Ikemura K; Takaoka M; Moriguchi S; Iino T; Kusumoto A; Asami S; Shibata H; Kiso Y; Matsumura Y
Biosci Biotechnol Biochem; 2006 May; 70(5):1118-26. PubMed ID: 16717411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
